C102H256O150P50 — CID 140627932
[1-(2,4,6,8,10,12,14,16,18,20-decaphosphonodocosyl)-3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67,69,71,73,75,77,79-nonatriacontaphosphonooctacontyl]phosphonic acid (PubChem CID 140627932) has the molecular formula C102H256O150P50 and a molecular weight of 5431.72 g/mol. Its IUPAC name is [1-(2,4,6,8,10,12,14,16,18,20-decaphosphonodocosyl)-3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67,69,71,73,75,77,79-nonatriacontaphosphonooctacontyl]phosphonic acid.
| Compound Name | [1-(2,4,6,8,10,12,14,16,18,20-decaphosphonodocosyl)-3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67,69,71,73,75,77,79-nonatriacontaphosphonooctacontyl]phosphonic acid |
|---|---|
| PubChem CID | 140627932 |
| Molecular Formula | C102H256O150P50 |
| Molecular Weight | 5431.72 g/mol |
| Exact Mass | 5429.93 |
| IUPAC Name | [1-(2,4,6,8,10,12,14,16,18,20-decaphosphonodocosyl)-3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67,69,71,73,75,77,79-nonatriacontaphosphonooctacontyl]phosphonic acid |
| SMILES | CCC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(CC(C)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O)P(=O)(O)O |
| InChI | InChI=1S/C102H256O150P50/c1-3-54(254(106,107)108)5-56(256(112,113)114)7-58(258(118,119)120)9-60(260(124,125)126)11-62(262(130,131)132)13-64(264(136,137)138)15-66(266(142,143)144)17-68(268(148,149)150)19-70(270(154,155)156)21-72(272(160,161)162)23-74(274(166,167)168)25-76(276(172,173)174)27-78(278(178,179)180)29-80(280(184,185)186)31-82(282(190,191)192)33-84(284(196,197)198)35-86(286(202,203)204)37-88(288(208,209)210)39-90(290(214,215)216)41-92(292(220,221)222)43-94(294(226,227)228)45-96(296(232,233)234)47-98(298(238,239)240)49-100(300(244,245)246)51-102(302(250,251)252)52-101(301(247,248)249)50-99(299(241,242)243)48-97(297(235,236)237)46-95(295(229,230)231)44-93(293(223,224)225)42-91(291(217,218)219)40-89(289(211,212)213)38-87(287(205,206)207)36-85(285(199,200)201)34-83(283(193,194)195)32-81(281(187,188)189)30-79(279(181,182)183)28-77(277(175,176)177)26-75(275(169,170)171)24-73(273(163,164)165)22-71(271(157,158)159)20-69(269(151,152)153)18-67(267(145,146)147)16-65(265(139,140)141)14-63(263(133,134)135)12-61(261(127,128)129)10-59(259(121,122)123)8-57(257(115,116)117)6-55(255(109,110)111)4-53(2)253(103,104)105/h53-102H,3-52H2,1-2H3,(H2,103,104,105)(H2,106,107,108)(H2,109,110,111)(H2,112,113,114)(H2,115,116,117)(H2,118,119,120)(H2,121,122,123)(H2,124,125,126)(H2,127,128,129)(H2,130,131,132)(H2,133,134,135)(H2,136,137,138)(H2,139,140,141)(H2,142,143,144)(H2,145,146,147)(H2,148,149,150)(H2,151,152,153)(H2,154,155,156)(H2,157,158,159)(H2,160,161,162)(H2,163,164,165)(H2,166,167,168)(H2,169,170,171)(H2,172,173,174)(H2,175,176,177)(H2,178,179,180)(H2,181,182,183)(H2,184,185,186)(H2,187,188,189)(H2,190,191,192)(H2,193,194,195)(H2,196,197,198)(H2,199,200,201)(H2,202,203,204)(H2,205,206,207)(H2,208,209,210)(H2,211,212,213)(H2,214,215,216)(H2,217,218,219)(H2,220,221,222)(H2,223,224,225)(H2,226,227,228)(H2,229,230,231)(H2,232,233,234)(H2,235,236,237)(H2,238,239,240)(H2,241,242,243)(H2,244,245,246)(H2,247,248,249)(H2,250,251,252) |
| InChIKey | FOXUWQMSANBYKK-UHFFFAOYSA-N |
| XLogP | -2.15 |
| TPSA | 2876.50 Ų |
| H-Bond Donors | 100 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 149 |
| Heavy Atoms | 302 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5431.72 |
| LogP ≤ 5 | -2.15 |
| H-Bond Donors ≤ 5 | 100 |
| H-Bond Acceptors ≤ 10 | 50 |